These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 20025723)

  • 1. Identifying significant genetic regulatory networks in the prostate cancer from microarray data based on transcription factor analysis and conditional independency.
    Yeh HY; Cheng SW; Lin YC; Yeh CY; Lin SF; Soo VW
    BMC Med Genomics; 2009 Dec; 2():70. PubMed ID: 20025723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factor and microRNA regulation in androgen-dependent and -independent prostate cancer cells.
    Wang G; Wang Y; Feng W; Wang X; Yang JY; Zhao Y; Wang Y; Liu Y
    BMC Genomics; 2008 Sep; 9 Suppl 2(Suppl 2):S22. PubMed ID: 18831788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust gene network analysis reveals alteration of the STAT5a network as a hallmark of prostate cancer.
    Reddy A; Huang CC; Liu H; Delisi C; Nevalainen MT; Szalma S; Bhanot G
    Genome Inform; 2010; 24():139-53. PubMed ID: 22081596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of open chromosomal regions and key genes in prostate cancer via integrated analysis of DNase‑seq and RNA‑seq data.
    Wei X; Yu L; Jin X; Song L; Lv Y; Han Y
    Mol Med Rep; 2018 Aug; 18(2):2245-2252. PubMed ID: 29956775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer.
    Kunderfranco P; Mello-Grand M; Cangemi R; Pellini S; Mensah A; Albertini V; Malek A; Chiorino G; Catapano CV; Carbone GM
    PLoS One; 2010 May; 5(5):e10547. PubMed ID: 20479932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells.
    Singh AP; Bafna S; Chaudhary K; Venkatraman G; Smith L; Eudy JD; Johansson SL; Lin MF; Batra SK
    Cancer Lett; 2008 Jan; 259(1):28-38. PubMed ID: 17977648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochip analysis of prostate cancer.
    Fan MQ; Wang PX; Feng JY; Xiao Y; Huang CB
    Genet Mol Res; 2014 Jan; 13(1):152-9. PubMed ID: 24446298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
    Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
    Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-platform method for identifying candidate network biomarkers for prostate cancer.
    Jin G; Zhou X; Cui K; Zhang XS; Chen L; Wong ST
    IET Syst Biol; 2009 Nov; 3(6):505-12. PubMed ID: 19947776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of diagnosis system and gene regulatory networks based on microarray analysis.
    Hong CF; Chen YC; Chen WC; Tu KC; Tsai MH; Chan YK; Yu SS
    J Biomed Inform; 2018 May; 81():61-73. PubMed ID: 29550394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA and Transcription Factor Gene Regulatory Network Analysis Reveals Key Regulatory Elements Associated with Prostate Cancer Progression.
    Sadeghi M; Ranjbar B; Ganjalikhany MR; M Khan F; Schmitz U; Wolkenhauer O; Gupta SK
    PLoS One; 2016; 11(12):e0168760. PubMed ID: 28005952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A visual data mining tool that facilitates reconstruction of transcription regulatory networks.
    Jupiter DC; VanBuren V
    PLoS One; 2008 Mar; 3(3):e1717. PubMed ID: 18320038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constructing Bayesian networks by integrating gene expression and copy number data identifies NLGN4Y as a novel regulator of prostate cancer progression.
    Gong Y; Wang L; Chippada-Venkata U; Dai X; Oh WK; Zhu J
    Oncotarget; 2016 Oct; 7(42):68688-68707. PubMed ID: 27626693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MICRAT: a novel algorithm for inferring gene regulatory networks using time series gene expression data.
    Yang B; Xu Y; Maxwell A; Koh W; Gong P; Zhang C
    BMC Syst Biol; 2018 Dec; 12(Suppl 7):115. PubMed ID: 30547796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive gene expression microarray analysis of Ets-1 blockade in PC3 prostate cancer cells and correlations with prostate cancer tissues: Insights into genes involved in the metastatic cascade.
    Adler D; Lindstrot A; Langer B; Buettner R; Wernert N
    Int J Mol Med; 2011 Jun; 27(6):811-9. PubMed ID: 21424114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
    Ye Y; Li SL; Wang SY
    PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying molecular features for prostate cancer with Gleason 7 based on microarray gene expression profiles.
    Bălăcescu L; Bălăcescu O; Crişan N; Fetica B; Petruţ B; Bungărdean C; Rus M; Tudoran O; Meurice G; Irimie A; Dragoş N; Berindan-Neagoe I
    Rom J Morphol Embryol; 2011; 52(4):1195-202. PubMed ID: 22203922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inferring large-scale gene regulatory networks using a low-order constraint-based algorithm.
    Wang M; Augusto Benedito V; Xuechun Zhao P; Udvardi M
    Mol Biosyst; 2010 Jun; 6(6):988-98. PubMed ID: 20485743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional network modulated by the prognostic signature transcription factors and their long noncoding RNA partners in primary prostate cancer.
    Jiang M; Cheng Y; Wang D; Lu Y; Gu S; Wang C; Huang Y; Li Y
    EBioMedicine; 2021 Jan; 63():103150. PubMed ID: 33279858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.